1. Carabello BA. Mitral regurgitation: basic pathophysiologic principles,part 1. Mod Concepts Cardiovasc Dis 1988;57:53– 8.
2. Castello R, Fagan L Jr, Lenzen P, Pearson AC, Labovitz AJ.Comparison of transthoracic and transesophageal echocardiographyfor assessment of leftsided valvular regurgitation. Am J Cardiol1991;68:1677– 80.
3. Connolly MW, Gelbfish JS, Jacobowitz IJ, et al. Surgical results formitral regurgitation from coronary artery disease. J Thorac CardiovascSurg 1986;91:379–88.
4. Cohn LH, Couper GS, Kinchla NM, Collins JJ Jr. Decreasedoperative risk of surgical treatment of mitral regurgitation with orwithout coronary artery disease. J Am Coll Cardiol 1990;16:1575–8.
5. Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RW, SonnenblickEH. Mechanism of reduction of mitral regurgitation withvasodilator therapy. Am J Cardiol 1979;43:773–7.
6. Chatterjee K, Parmley WW, Swan HJ, Berman G, Forrester J,Marcus HS. Beneficial effects of vasodilator agents in severe mitralregurgitation due to dysfunction of subvalvar apparatus. Circulation1973;48:684 –90.
7. Enriquez-Sarano M, Basmadjian AJ, Rossi A, Bailey KR, SewardJB, Tajik AJ. Progression of mitral regurgitation: a prospectiveDoppler echocardiographic study. J Am Coll Cardiol 1999;34:1137–44.
8. Zile MR, Gaasch WH, Carroll JD, Levine HJ. Chronic mitralregurgitation: predictive value of preoperative echocardiographicindexes of left ventricular function and wall stress. J Am CollCardiol 1984;3:235– 42.
9. Schuler G, Peterson KL, Johnson A, et al. Temporal response of leftventricular performance to mitral valve surgery. Circulation 1979;59:1218 –31.
10. Carabello BA, Nolan SP, McGuire LB. Assessment of preoperativeleft ventricular function in patients with mitral regurgitation: valueof the end-systolic wall stress-end-systolic volume ratio. Circulation1981;64:1212–7.
11. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al.Quantitative determinants of the outcome of asymptomatic mitralregurgitation. N Engl J Med 2005;352:875– 83.
12. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waitingin asymptomatic severe mitral regurgitation. Circulation 2006;113:2238–44.
13. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact of preoperative symptoms on survival after surgical correction oforganic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999; 99: 400 –5.
14. Crawford MH, Souchek J, Oprian CA, et al. Determinants ofsurvival and left ventricular performance after mitral valve replacement:Department of Veterans Affairs Cooperative Study on ValvularHeart Disease. Circulation 1990;81:1173– 81.
15. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, BaileyKR, Frye RL. Valve repair improves the outcome of surgery formitral regurgitation: a multivariate analysis. Circulation 1995;91:1022–8.
16. Enriquez-Sarano M, Tribouilloy C. Quantitation of mitral regurgitation: rationale, approach, and interpretation in clinical practice.Heart 2002; 88 Suppl 4:iv1–3.
17. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary. J Am Col Card 2014; Vol 63; 22.
18. Carpentier A. Cardiac valve surgery — the “French correction”. J Thorac Cardiovasc Surg 1983; 86:323–37.
19. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; doi:10.1093
20. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, BaileyKR, Frye RL. Echocardiographic prediction of survival after surgicalcorrection of organic mitral regurgitation. Circulation 1994;90:830–7.
21. Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographicprediction of left ventricular function after correction of mitralregurgitation: results and clinical implications. J Am Coll Cardiol1994;24:1536–43.
22. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome aftervalve replacement for rheumatic mitral regurgitation in the era ofchordal preservation. Circulation 1994;89:191–7.
23. Flemming MA, Oral H, Rothman ED, Briesmiester K, PetrushaJA, Starling MR. Echocardiographic markers for mitral valvesurgery to preserve left ventricular performance in mitral regurgitation.Am Heart J 2000;140:476–82.
24. Corin WJ, Monrad ES, Murakami T, Nonogi H, Hess OM,Krayenbuehl HP. The relationship of afterload to ejection performancein chronic mitral regurgitation. Circulation 1987;76:59–67.
25. Gaasch WH, Zile MR. Left ventricular function after surgicalcorrection of chronic mitral regurgitation. Eur Heart J 1991;12Suppl B:48 –51.
26. Host U, Kelbaek H, Hildebrandt P, Skagen K, Aldershvile J. Effectof ramipril on mitral regurgitation secondary to mitral valve prolapse.Am J Cardiol 1997;80:655– 8.
27. Marcotte F, Honos GN, Walling AD, et al. Effect of angiotensinconvertingenzymeinhibitor therapy in mitral regurgitation withnormal left ventricular function. Can J Cardiol 1997;13:479–85.
28. Tischler MD, Rowan M, LeWinter MM. Effect of enalapriltherapy on left ventricular mass and volumes in asymptomaticchronic, severe mitral regurgitation secondary to mitral valve prolapse.Am J Cardiol 1998;82:242–5.
29. Dell’Italia LJ, Meng QC, Balcells E, et al. Compartmentalization ofangiotensin II generation in the dog heart: evidence for independentmechanisms in intravascular and interstitial spaces. J Clin Invest1997;100: 253–8.
30. Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy inchronic heart failure: diastolic function and mitral regurgitationimprovement by carvedilol. Am Heart J 2000;139:596–608.
31. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricularpacing in congestive heart failure: results from the MUltisiteSTimulation In Cardiomyopathy (MUSTIC) study. J Am CollCardiol 2002;40:111– 8.